google-site-verification: googlec7193c3de77668c9.html

Blood-based marker opens up perspectives for cancer diagnostics

[
Metastatic prostate cancer is currently associated with high morbidity and mortality rates. In addition, patients respond very differently to standard treatments such as hormone therapy or radiation therapy. Reliable markers that can be used to predict aggressive tumor progression and treatment success at an early stage are still largely lacking.


Source link

Advertisements
Views: 1

See also  Rethinking brain-like artificial intelligence: New study reveals hidden mismatches

Check Also

Weight loss treatments linked to lower risk of obesity-related cancers in people without diabetes

[ Credit: Unsplash/CC0 Public Domain A study of more than 229,000 obese adults without diabetes …

A good night’s sleep begins with healthy gut bacteria. Here’s how to look after yours

[ Credit: Pixabay/CC0 Public Domain It’s no accident that we spend a third of our …

Simple leukemia treatment change in India cuts early child deaths

[ A landmark Indian clinical trial has found that giving steroids in short bursts instead …

Leave a Reply

Available for Amazon Prime
Link. 429 too many requests.